Denali Therapeutics Inc (DNLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 4,197 | 4,205 | 125,676 | 1,195 | 1,648 |
| Gross Profit | 4,197 | 4,205 | 125,676 | 1,195 | 1,648 |
| Operating Expenses | 66,960 | 46,713 | 50,954 | 39,159 | 59,030 |
| Operating Income | -62,763 | -42,508 | 74,722 | -37,964 | -57,382 |
| Other Income | 4,113 | 3,516 | 2,811 | 2,593 | 2,658 |
| Pre-tax Income | -58,650 | -38,992 | 77,533 | -35,371 | -54,724 |
| Income Tax | -313 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -58,337 | -38,992 | 77,533 | -35,371 | -54,724 |
| Net Income | $-58,337 | $-38,992 | $77,533 | $-35,371 | $-54,724 |
| EPS Basic Total Ops | -0.61 | -0.41 | 0.84 | -0.38 | -0.59 |
| EPS Basic Continuous Ops | -0.61 | -0.41 | 0.84 | -0.38 | -0.59 |
| EPS Diluted Total Ops | -0.61 | -0.41 | 0.84 | -0.38 | -0.59 |
| EPS Diluted Continuous Ops | -0.61 | -0.41 | 0.84 | -0.38 | -0.59 |
| EBITDA(a) | $-62,537 | $-41,422 | $76,260 | $-36,409 | $-56,232 |